国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

美國Covidien
Covidien(柯惠)的前身是泰科醫療(Tyco Healthcare)。
Covidien Ltd（紐約證券交易所：COV、百慕大證券交易所：COV）是全球領(lǐng)先的衛生保健產(chǎn)品公司，其創(chuàng )建革新的醫療解決方案，通過(guò)臨床領(lǐng)導能力及卓越的表現來(lái)使病人實(shí)現更好的結果，并實(shí)現價(jià)值。Covidien制造、分銷(xiāo)多種業(yè)界領(lǐng)先的產(chǎn)品線(xiàn)，并為這些產(chǎn)品線(xiàn)提供服務(wù)，包括外科設備、基于能量的設備、呼吸和監控解決方案、病人護理與安全產(chǎn)品、影像解決方案、醫藥產(chǎn)品、醫療用品。2006年，Covidien的收入達到近100億美元，在世界上的57個(gè)國家中雇有43,000名員工，其產(chǎn)品銷(xiāo)往130多個(gè)國家。2007年7月2號開(kāi)始在紐約證券交易所和百慕大證券交易所進(jìn)行交易，這意味著(zhù)公司首次成為獨立的多元化醫療保健產(chǎn)品公司。這也表示眾所周知的Tyco Healthcare業(yè)務(wù)最近從Tyco International中正獨立。

　　憑借業(yè)界領(lǐng)先的品牌名稱(chēng)（包括：Autosuture、Kendall、Mallinckrodt、Nellcor、Puritan Bennett、Syneture、U.S.Surgical和Valleylab），Covidien在醫療設備、影像解決方案、醫藥產(chǎn)品、醫療用品以及零售產(chǎn)品產(chǎn)品等五大業(yè)務(wù)部門(mén)在市場(chǎng)上競爭。2006年，Covidien收益達到96億美元，其中三分之一以上的銷(xiāo)售額是在美國以外實(shí)現的。 Covidien在57個(gè)國家雇有43,000名員工，其產(chǎn)品銷(xiāo)往130多個(gè)國家。

Covidien五大業(yè)務(wù)部門(mén)的特色
　　醫療設備部（占銷(xiāo)售的59％）

醫療設備部是最大的業(yè)務(wù)部門(mén)，在2006年其凈銷(xiāo)售額達到了57億美元。
這一多樣化產(chǎn)品部門(mén)在多種醫療設備市場(chǎng)是全球領(lǐng)先者，其單一產(chǎn)品的銷(xiāo)售額不超過(guò)總銷(xiāo)售額的1％。
體現了Covidien在全球廣泛的足跡，醫療設備銷(xiāo)售中有54％是在美國以外實(shí)現的。
對于外科設備、能量設備、呼吸和監控解決方案、病人護理和安全產(chǎn)品以及眾多革新產(chǎn)品來(lái)說(shuō)，醫療設備部是最重要的部門(mén)。
　　影像解決方案部（占銷(xiāo)售的9％）　　

在2006年，影像解決方案產(chǎn)品的凈銷(xiāo)售額達90億美元。
Covidien影像解決方案部以最精確的早期疾病診斷為終極目標，在生產(chǎn)多種形態(tài)的放射性藥劑（X-ray、MRI和核醫療）、造影劑和造影交付系統方面是全球領(lǐng)先者。
遵循全企業(yè)創(chuàng )新哲學(xué)，影像解決方案部將醫療影像技術(shù)從注重‘解剖和功能影像技術(shù)轉移到‘分子級影像技術(shù)’上。這種轉變可幫助臨床醫生在更早的階段進(jìn)行疾病診斷、治療和監控。
　　醫藥產(chǎn)品部（占銷(xiāo)售額的13％）

2006年實(shí)現的凈銷(xiāo)售額達到12億美元，擁有多個(gè)產(chǎn)品線(xiàn)，從配藥醫藥品到藥物活性成分以及特制化學(xué)產(chǎn)品。
Covidien是美國第九大醫藥公司（擁有眾多配藥處方）
作為世界上控制中樞神經(jīng)類(lèi)物質(zhì)的最大制造商，Covidien是病人安全與及控制中樞神經(jīng)類(lèi)物質(zhì)調節方面的先驅。
Covidien也是醋氨酚以及其它多種止痛藥品的全球領(lǐng)先者
　　醫療用品部（占銷(xiāo)售額的10％）

在2006年凈銷(xiāo)售額達近10億美元，醫療用品部是病人護理材料領(lǐng)域的領(lǐng)先者。
Covidien的各種產(chǎn)品讓手術(shù)室、護理站和醫師的辦公室中擁有最高質(zhì)量的臨床材料。
產(chǎn)品線(xiàn)包括：傷口護理材料、醫療外科產(chǎn)品、原始設備制造商產(chǎn)品、失禁用品（歐洲）以及其它產(chǎn)品。
在核心醫療用品類(lèi)中，Covidien的市場(chǎng)份額位居第一或第二。
　　零售產(chǎn)品部（占銷(xiāo)售額的9％）

在零售產(chǎn)品部門(mén)，Covidien是北美地區自有品牌成人失禁產(chǎn)品、嬰兒護理產(chǎn)品以及女性衛生產(chǎn)品領(lǐng)域的領(lǐng)先制造商，在2006年的凈銷(xiāo)售額達到8億美元。
在美國20家頂級零售商中，Covidien是為17家提供自有品牌成人失禁產(chǎn)品、嬰兒護理產(chǎn)品以及女性衛生產(chǎn)品的獨家或者多家授權供貨商。

At Covidien, we're passionate about making doctors, nurses, pharmacists and other medical professionals as effective as they can be. From Autosuture to Valleylab, from Kendall to Mallinckrodt, our industry-leading brands are known worldwide for uncompromising quality.

Through ongoing collaboration with medical professionals and organizations, we identify clinical needs and translate them into proven products and procedures. Over the years, we've pioneered a number of medical advances including contrast media, pulse oximetry, electrosurgery, surgical stapling and laparoscopic instrumentation.

Offering an extensive product line that spans medical devices, imaging solutions, pharmaceuticals and medical supplies, we serve healthcare needs in hospitals, long-term care and alternate care facilities, doctors’ offices and in the home.

International in every respect Covidien is part of the local fabric of the communities where we operate. Deriving 45% of our sales from outside the United States, Covidien's success wouldn’t be possible without the dedication of our 41,000 employees, who live in 59 countries. More than two-thirds of our colleagues work in 60 manufacturing facilities, located in 16 countries. In addition, more than 4,800 sales representatives in more than 50 countries meet our customers’ needs every day.

Strategic Initiatives, Core strengths At Covidien, we believe that supporting the lifesaving work of medical professionals and emphasizing growth are not mutually exclusive. In fact, our financial stability enables us to hold to our vision of being an essential resource to the healthcare profession and therefore to doing our part to improve patient outcomes.

With that in mind, we have outlined the following strategic initiatives:

Focus on Growth
Commitment to Innovation
Leveraging Our Global Structure
Driving Operational Excellence
Increased Portfolio Management
We're confident that we will succeed in these areas because of our core strengths:

Scale, product diversity and reach. As one of the largest global manufacturers and marketers in the healthcare industry, our scale and diversity allow us to invest wisely in infrastructure and technology and to develop lower cost sources of supply and global distribution. We offer products in a number of high growth healthcare areas, including laparoscopic surgery, electrosurgery, biosurgery, sleep therapy and pain management.
A portfolio of leading brands. Our brands are among the most well-known and respected in the healthcare field. Quality and reliability are their hallmarks.
Strong customer relationships. Our sales force develops and maintains strong relationships with clinician decision makers. We foster these relationships by providing extensive clinical education through dedicated training centers, by sponsoring fellowships and offering other continuing education programs.
Operational excellence. We have a history of developing and manufacturing high-quality products in a cost-effective manner. Throughout our organization, we are committed to Six Sigma, Design for Six Sigma, Lean Manufacturing and strategic sourcing initiatives to ensure product availability. We employ strict safety and quality controls to reduce disruption throughout the supply chain.
Our aim is to enhance growth by increasing research and development initiatives, pursuing targeted acquisition opportunities and enhancing our global infrastructure, including sales, marketing and distribution.